BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10440619)

  • 1. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.
    Morrison BW; Christensen S; Yuan W; Brown J; Amlani S; Seidenberg B
    Clin Ther; 1999 Jun; 21(6):943-53. PubMed ID: 10440619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
    Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
    Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model.
    Malmstrom K; Fricke JR; Kotey P; Kress B; Morrison B
    Clin Ther; 2002 Oct; 24(10):1549-60. PubMed ID: 12462285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral rofecoxib versus intravenous ketoprofen as an adjuvant to PCA morphine after urologic surgery.
    Cabrera MC; Schmied S; Derderian T; White PF; Vega R; Santelices E; Verdugo F
    Acta Anaesthesiol Scand; 2004 Oct; 48(9):1190-3. PubMed ID: 15352968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model.
    Ehrich EW; Dallob A; De Lepeleire I; Van Hecken A; Riendeau D; Yuan W; Porras A; Wittreich J; Seibold JR; De Schepper P; Mehlisch DR; Gertz BJ
    Clin Pharmacol Ther; 1999 Mar; 65(3):336-47. PubMed ID: 10096266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group.
    Ehrich EW; Schnitzer TJ; McIlwain H; Levy R; Wolfe F; Weisman M; Zeng Q; Morrison B; Bolognese J; Seidenberg B; Gertz BJ
    J Rheumatol; 1999 Nov; 26(11):2438-47. PubMed ID: 10555907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valdecoxib versus rofecoxib in acute postsurgical pain: results of a randomized controlled trial.
    Christensen KS; Cawkwell GD
    J Pain Symptom Manage; 2004 May; 27(5):460-70. PubMed ID: 15120774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model.
    Khan AA; Brahim JS; Rowan JS; Dionne RA
    Clin Pharmacol Ther; 2002 Jul; 72(1):44-9. PubMed ID: 12152003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rofecoxib and oxycodone plus acetaminophen in the treatment of acute pain: a randomized, double-blind, placebo-controlled study in patients with moderate to severe postoperative pain in the third molar extraction model.
    Korn S; Vassil TC; Kotey PN; Fricke JR
    Clin Ther; 2004 May; 26(5):769-78. PubMed ID: 15220020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial.
    Chang DJ; Fricke JR; Bird SR; Bohidar NR; Dobbins TW; Geba GP
    Clin Ther; 2001 Sep; 23(9):1446-55. PubMed ID: 11589259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans.
    Schwartz JI; Chan CC; Mukhopadhyay S; McBride KJ; Jones TM; Adcock S; Moritz C; Hedges J; Grasing K; Dobratz D; Cohen RA; Davidson MH; Bachmann KA; Gertz BJ
    Clin Pharmacol Ther; 1999 Jun; 65(6):653-60. PubMed ID: 10391671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials.
    Morrison BW; Fricke J; Brown J; Yuan W; Kotey P; Mehlisch D
    J Am Dent Assoc; 2000 Dec; 131(12):1729-37. PubMed ID: 11143737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial.
    Chang DJ; Desjardins PJ; Chen E; Polis AB; McAvoy M; Mockoviak SH; Geba GP
    Clin Ther; 2002 Apr; 24(4):490-503. PubMed ID: 12017395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain.
    Reicin A; Brown J; Jove M; deAndrade JR; Bourne M; Krupa D; Walters D; Seidenberg B
    Am J Orthop (Belle Mead NJ); 2001 Jan; 30(1):40-8. PubMed ID: 11198829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
    Katz N; Ju WD; Krupa DA; Sperling RS; Bozalis Rodgers D; Gertz BJ; Gimbel J; Coleman S; Fisher C; Nabizadeh S; Borenstein D;
    Spine (Phila Pa 1976); 2003 May; 28(9):851-8; discussion 859. PubMed ID: 12941996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.
    Higuchi T; Iwama T; Yoshinaga K; Toyooka M; Taketo MM; Sugihara K
    Clin Cancer Res; 2003 Oct; 9(13):4756-60. PubMed ID: 14581346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial.
    Misra UK; Jose M; Kalita J
    Postgrad Med J; 2004 Dec; 80(950):720-3. PubMed ID: 15579612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain.
    Desjardins PJ; Black PM; Daniels S; Bird SR; Fitzgerald BJ; Petruschke RA; Tershakovec A; Chang DJ
    Curr Med Res Opin; 2004 Oct; 20(10):1523-37. PubMed ID: 15462686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of prophylactic use of rofecoxib in comparison with ibuprofen on postendodontic pain.
    Gopikrishna V; Parameswaran A
    J Endod; 2003 Jan; 29(1):62-4. PubMed ID: 12540224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.